Vignesh Sakthivelu

Vignesh Sakthivelu

Auto-generated profile, based on publicly available information

Vignesh Sakthivelu

Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2025 in Nature
Verified
Journal Article
Open access
VSVignesh Sakthivelu
Vignesh Sakthivelu
ASAnna Schmitt
Anna Schmitt
FOFranka Odenthal
Franka Odenthal
KNKristiano Ndoci
Kristiano Ndoci
MTMarian Touet
Marian Touet
FBFilippo Beleggia
Filippo Beleggia
Small cell lung cancer (SCLC) is a highly aggressive type of lung cancer, characterized by rapid proliferation, early metastatic spread, frequent early relapse and a high mortality rate 1–3 . Recent evidence has suggested that innervation has an important role in the development and progression of several types of cancer 4,5 . Cancer-to-neuron synapses have been reported in gliomas 6,7 , but whether peripheral tumours can form such structures is unknown. Here we show that SCLC cells can form functional synapses and receive synaptic transmission. Using in vivo insertional mutagenesis screening in conjunction with cross-species genomic and transcriptomic validation, we identified neuronal, synaptic and glutamatergic signalling gene sets in mouse and human SCLC. Further experiments revealed the ability of SCLC cells to form synaptic structures with neurons in vitro and in vivo. Electrophysiology and optogenetic experiments confirmed that cancer cells can receive NMDA receptor- and GABA A receptor-mediated synaptic inputs. Fitting with a potential oncogenic role of neuron–SCLC interactions, we showed that SCLC cells derive a proliferation advantage when co-cultured with vagal sensory or cortical neurons. Moreover, inhibition of glutamate signalling had therapeutic efficacy in an autochthonous mouse model of SCLC. Therefore, following malignant transformation, SCLC cells seem to hijack synaptic signalling to promote tumour growth, thereby exposing a new route for therapeutic intervention.

18 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
AAAriadne Androulidaki
Ariadne Androulidaki
FLFanyu Liu
Fanyu Liu
CBChristina M. Bebber
Christina M. Bebber
IKIlmars Kisis
Ilmars Kisis
VSVignesh Sakthivelu
Vignesh Sakthivelu
SKSilvia Von Karstedt
Silvia Von Karstedt
Most neuroendocrine cancers lack caspase 8 protein expression. While this feature was thought to facilitate escape from extrinsic apoptosis, its cancer-regulatory function has remained unexplored. Here, we devise a mouse model of small cell lung cancer (SCLC) recapitulating the lack of expression of caspase 8 seen in humans and uncover an unexpected role for necroptosis-fueled pre-tumoral inflammation resulting in reprogramming towards a neuronal progenitor cell-like state and increased metastatic disease. Notably, transcriptional signatures of this cellular state are enriched in relapsed and metastatic human SCLC. Mechanistically, caspase 8 loss within the pre-tumoral niche promotes inflammation marked by increased recruitment of regulatory T cells (Tregs) which are responsible for the promotion of metastatic disease. Importantly, inactivation of the necroptosis executioner MLKL reverses pre-tumoral inflammation, decreases metastasis as well as neuronal-like reprogramming. Taken together, our findings suggest that pre-tumoral inflammatory cell death contributes to neuronal progenitor mimicry, immunosuppression and increased metastasis in SCLC.

19 September 2025 in Nature
Verified
Journal Article
Open access
PDF file
VSVignesh Sakthivelu
Vignesh Sakthivelu
ASAnna Schmitt
Anna Schmitt
FOFranka Odenthal
Franka Odenthal
KNKristiano Ndoci
Kristiano Ndoci
MTMarian Touet
Marian Touet
FBFilippo Beleggia
Filippo Beleggia